Series B Preferred Shares. A total of 25,537,431 authorized Series B Preferred Shares, par value of US$0.0001 (“Series B Preferred Shares, and each a “Series B Preferred Share”), all of which are issued and outstanding. The rights, privileges and preferences of the Series B Preferred Shares are as stated in the Amended M&A as provided by the Company Law.
Appears in 2 contracts
Samples: Series C Preferred Share Purchase Agreement (Burning Rock Biotech LTD), Series C Preferred Share Purchase Agreement (Burning Rock Biotech LTD)
Series B Preferred Shares. A total of 25,537,431 28,303 authorized Series B Preferred Shares, par value of US$0.0001 (“Series B Preferred Shares, and each a “Series B Preferred Share”)per share, all of which are issued and outstanding. The rights, privileges and preferences of the Series B Preferred Shares are as stated in the Amended M&A as provided by the Company Law.; and
Appears in 2 contracts
Samples: Share Subscription Agreement (9F Inc.), Share Subscription Agreement (9F Inc.)
Series B Preferred Shares. A total of 25,537,431 28,303 authorized Series B Preferred Shares, par value of US$0.0001 (“Series B Preferred Sharesper share, and each a “Series B Preferred Share”), all none of which are issued and outstanding. The rights, privileges and preferences of the Series B Preferred Shares are as stated in the Amended M&A as provided by the Company Law.
Appears in 2 contracts
Samples: Share Subscription Agreement (9F Inc.), Share Subscription Agreement (9F Inc.)
